Application

16867398 · MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

Filed 2020-05-05 · Abandoned The official file ↗ · Art unit 1646 · Examiner Ruixiang Li Typical · CPC C07K 16/2863 · GALAXY BIOTECH, LLC · Marshall, Gerstein & Borun LLP (Amgen)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

21.6 mo

to disposition 34.6 mo

Statutes raised

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.